ConductScience.org, home

Paper41300964

Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions.

Sarti S and 13 others. Cancers (Basel), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions. Papers, record 41300964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300964

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-11-30
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sarti SSamanta
2Viansone AAAlessandro Adriano
3Serra OOlgahttps://orcid.org/0009-0003-6282-5809
4Casadei CChiarahttps://orcid.org/0000-0003-2467-749X
5Cecconetto LLorenzo
6Di Menna GGiandomenico
7Farolfi AAlberto
8Gianni CCaterinahttps://orcid.org/0000-0001-9496-6719
9Mariotti MMaritahttps://orcid.org/0000-0001-5258-1917
10Merloni FFilippohttps://orcid.org/0009-0005-8149-9740
11Palleschi MMichelahttps://orcid.org/0000-0003-2623-4705
12Sirico MMarianna
13Zoppoli GGabrielehttps://orcid.org/0000-0002-1619-1708
14Musolino AAntoninohttps://orcid.org/0000-0002-7979-6261

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GOIRC2025Italian Oncology Group of Clinical ResearchPubMed

Source PubMed

Download CSV of grants

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125858804Immune checkpoint blockade: a common denominator approach to cancer therapy.Cancer Cell2015https://conductscience.org/library/papers/25858804PubMed
222580612MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.Oncogene2013https://conductscience.org/library/papers/22580612PubMed
316034008Benign breast disease and the risk of breast cancer.N Engl J Med2005https://conductscience.org/library/papers/16034008PubMed
439513557Most young female cancer survivors are at minimal risk for obstetric problems.CA Cancer J Clin2024https://conductscience.org/library/papers/39513557PubMed
520512124An autoimmune-mediated strategy for prophylactic breast cancer vaccination.Nat Med2010https://conductscience.org/library/papers/20512124PubMed
635584336
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
J Clin Oncol2022https://conductscience.org/library/papers/35584336PubMed
728661758Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).J Clin Oncol2017https://conductscience.org/library/papers/28661758PubMed
831022829A Comparison of Plasmid DNA and mRNA as Vaccine Technologies.Vaccines (Basel)2019https://conductscience.org/library/papers/31022829PubMed
929404275Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV).Front Oncol2018https://conductscience.org/library/papers/29404275PubMed
1022747619The development and validation of the hypertension evaluation of lifestyle and management knowledge scale.J Clin Hypertens (Greenwich)2012https://conductscience.org/library/papers/22747619PubMed
1137490322Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review.J Med Internet Res2023https://conductscience.org/library/papers/37490322PubMed
1231474332Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.Lancet2019https://conductscience.org/library/papers/31474332PubMed
1316754727Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.JAMA2006https://conductscience.org/library/papers/16754727PubMed
1438704119Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.Contemp Clin Trials2024https://conductscience.org/library/papers/38704119PubMed
1527737975Identification and management of women with a family history of breast cancer: Practical guide for clinicians.Can Fam Physician2016https://conductscience.org/library/papers/27737975PubMed
1636131288Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results.BMC Health Serv Res2022https://conductscience.org/library/papers/36131288PubMed
1728465452Human Tumor Antigens Yesterday, Today, and Tomorrow.Cancer Immunol Res2017https://conductscience.org/library/papers/28465452PubMed
1837149701Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.Br J Cancer2023https://conductscience.org/library/papers/37149701PubMed
1931278729Review: Patient-controlled transdermal 4-hydroxytamoxifen (4-OHT) vs. oral tamoxifen: A systematic review and meta analysis.Pak J Pharm Sci2019https://conductscience.org/library/papers/31278729PubMed
202593165Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.J Natl Cancer Inst1989https://conductscience.org/library/papers/2593165PubMed

See all 88 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42774746Engineering probiotic consortia to improve chemotherapy tolerance and reduce toxicity in breast cancer patients: a new frontier in supportive precision oncology.Oncol Rev2026https://conductscience.org/library/papers/42774746PubMed
41943164Effect of VSOR/VRAC blocker tamoxifen on contractile activity of primary neonatal cardiomyocytes and isolated perfused heart.BMC Res Notes2026https://conductscience.org/library/papers/41943164PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300964

GET https://conductscience.org/api/papers/v1/41300964/references?page=2